-
The Economic Impact of Time-to-Target-Temperature of Different Surface Cooling Technologies for Temperature Management in Critically Ill Patients: A Systematic Review, Analysis, and Model
Sep 9, 2025, 16:22 PM -
Quantifying the Societal Value: Reduced Burden and Resource Savings From Baloxavir Marboxil's Influenza Transmission Protection in China
Sep 9, 2025, 16:22 PM -
Equality Considerations in NICE Guidance of Medical Devices Digital and Diagnostic Technologies and Interventional Procedures
Sep 9, 2025, 16:22 PM -
Surrogate Outcome Validation Within the New EU HTA Guidance Framework: Practical Considerations From an Industry Perspective Based on Experience From HTA Germany
Sep 9, 2025, 16:22 PM -
FLAME: An Open-Source Federated Platform for Deeply Phenotyped and Multimodal Studies at Population Scale
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ribociclib Plus Endocrine Therapy for the Treatment of HR/HER2 Early Breast Cancer in Greece
Sep 9, 2025, 16:22 PM -
Economic and Epidemiological Burden of Type 1 Diabetes In France
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Adult Vaccination Programs and HTA of Vaccines Approaches in the US, UK, and France: Lessons for Poland
Sep 9, 2025, 16:22 PM -
HDX vs. HDF in End-Stage Kidney Disease: Cost-Minimization Study in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Assessing the Sensitivity of EQ-5D-5L and AQoL-4D to Disease Severity in Von Willebrand Disease: Findings From UK Cohort of the PIVOT-vWD Study
Sep 9, 2025, 16:22 PM -
Life-Years Lost Due to Regulatory and Reimbursement Delays: A Study of Oncology Drugs Across England, Scotland, and France, 2022-2024
Sep 9, 2025, 16:22 PM -
Do We Need to Measure Social Impact of Innovative Drugs?
Sep 9, 2025, 16:22 PM -
Modeling the Clinical and Economic Impact of DPP-4 Inhibitors in Uncontrolled T2D
Sep 9, 2025, 16:22 PM -
Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States
Sep 9, 2025, 16:22 PM -
Differential Responsiveness and Minimally Important Difference of EQ-5D: Truth or Artifact?
Sep 9, 2025, 16:22 PM -
Pragmatic Advice to Improve Assessment Schedule of Preference-Based Measures of Health to Estimate Utilities in Clinical Trials
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Different Crown Materials for Dental Prosthesis From Budget in Wartime in Ukraine
Sep 9, 2025, 16:22 PM -
Reference Framework, Key Decision-Making Factors, and the Impact of Critical Parameters on Listing Recommendations for Nononcologic Drugs for Rare Diseases Issued by Canadian HTA Bodies
Sep 9, 2025, 16:22 PM -
The Impact of Intravesical Instillations on Quality of Life in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of High-Dose Trivalent Influenza Vaccine in the Elderly: A Cohort-Based Economic Model From the Italian NHS Perspective
Sep 9, 2025, 16:22 PM
